GENERATION BIO CO's ticker is GBIO and the CUSIP is 37148K100. A total of 96 filers reported holding GENERATION BIO CO in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $130,653 | -31.1% | 34,473 | 0.0% | 0.00% | – |
| Q2 2023 | $189,602 | +27.9% | 34,473 | 0.0% | 0.00% | – |
| Q1 2023 | $148,234 | +9.4% | 34,473 | 0.0% | 0.00% | – |
| Q4 2022 | $135,479 | -24.7% | 34,473 | +1.9% | 0.00% | – |
| Q3 2022 | $180,000 | -20.4% | 33,822 | -1.9% | 0.00% | – |
| Q2 2022 | $226,000 | -10.7% | 34,473 | 0.0% | 0.00% | – |
| Q1 2022 | $253,000 | -34.3% | 34,473 | -36.7% | 0.00% | -100.0% |
| Q4 2021 | $385,000 | -58.7% | 54,469 | +46.4% | 0.00% | -75.0% |
| Q3 2021 | $933,000 | -68.8% | 37,206 | -66.6% | 0.00% | -71.4% |
| Q2 2021 | $2,995,000 | – | 111,330 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Life Science Advisors, LLC | 8,278,876 | $58,614,000 | 5.38% |
| Yiheng Capital Management, L.P. | 1,975,146 | $13,984,000 | 0.71% |
| Artal Group S.A. | 2,814,191 | $19,924,000 | 0.54% |
| HARVARD MANAGEMENT CO INC | 510,354 | $3,613,000 | 0.34% |
| Bellevue Group AG | 3,872,180 | $27,416,000 | 0.28% |
| Casdin Capital, LLC | 1,324,275 | $9,376,000 | 0.26% |
| FARALLON CAPITAL MANAGEMENT LLC | 3,500,000 | $24,780,000 | 0.12% |
| BVF INC/IL | 189,050 | $1,338,000 | 0.05% |
| PDT Partners, LLC | 36,843 | $261,000 | 0.02% |
| GSA CAPITAL PARTNERS LLP | 17,739 | $126,000 | 0.02% |